AVENTIS PHARMA LIMITED

Active Reading

Wholesale of pharmaceutical goods

585 employees website.com
Wholesale of pharmaceutical goods
A

AVENTIS PHARMA LIMITED

Wholesale of pharmaceutical goods

Founded 18 Dec 1980 Active Reading, England 585 employees website.com
Wholesale of pharmaceutical goods

Previous Company Names

MARION MERRELL LIMITED 14 Sept 1995 — 16 Dec 1999
MARION MERRELL DOW LIMITED 6 Jan 1992 — 14 Sept 1995
MERRELL DOW PHARMACEUTICALS LIMITED 6 Dec 1983 — 6 Jan 1992
MERRELL PHARMACEUTICALS LIMITED 18 Dec 1980 — 6 Dec 1983
Accounts Submitted 5 Dec 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 5 Jan 2026 Next due 5 Jan 2027 8 months remaining
Net assets £1,415M £112M 2024 year on year
Total assets £1,859M £414M 2024 year on year
Total Liabilities £443M £302M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

410 Thames Valley Park Drive Reading Berkshire RG6 1PT England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for AVENTIS PHARMA LIMITED (01535640), an active company based in Reading, England. Incorporated 18 Dec 1980. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£131.00k

Decreased by £13.00k (-9%)

Net Assets

£1415.44M

Decreased by £111.86M (-7%)

Total Liabilities

£443.37M

Decreased by £302.09M (-41%)

Turnover

£414.63M

Increased by £16.85M (+4%)

Employees

585

Decreased by 81 (-12%)

Debt Ratio

24%

Decreased by 9 (-27%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 89,370,004 Shares £1322.08m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Nov 20204£1232.71m£308.18m
19 Dec 201989,370,000£89.37m£1

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Sanofi-aventis Uk Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

AVENTIS PHARMA LIMITED Current Company
FISONS LIMITED united kingdom
MAY & BAKER LIMITED united kingdom

Charges

Charges

1 outstanding

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
410 Thames Valley Park Drive, Reading (RG6 1PT) WOKINGHAM
Leasehold-30 Jan 2019
410 Thames Valley Park Drive, Reading (RG6 1PT)
Leasehold
Added 30 Jan 2019
District WOKINGHAM

Documents

Company Filings

DateCategoryDescriptionDocument
14 Apr 2026CapitalStatement by Directors
14 Apr 2026CapitalCapital Statement Capital Company With Date Currency Figure
14 Apr 2026ResolutionResolutions
14 Apr 2026InsolvencySolvency Statement dated 07/04/26
5 Feb 2026OfficersTermination of Usman Khan as director on 2026-02-01
14 Apr 2026 Capital

Statement by Directors

14 Apr 2026 Capital

Capital Statement Capital Company With Date Currency Figure

14 Apr 2026 Resolution

Resolutions

14 Apr 2026 Insolvency

Solvency Statement dated 07/04/26

5 Feb 2026 Officers

Termination of Usman Khan as director on 2026-02-01

Recent Activity

Latest Activity

Statement by Directors

1 weeks ago on 14 Apr 2026

Capital Statement Capital Company With Date Currency Figure

1 weeks ago on 14 Apr 2026

Resolutions

1 weeks ago on 14 Apr 2026

Solvency Statement dated 07/04/26

1 weeks ago on 14 Apr 2026

Termination of Usman Khan as director on 2026-02-01

2 months ago on 5 Feb 2026